Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Product/Service

Genetron Health Receives FDA Emergency Use Authorization for SARS-CoV-2 RNA Test and Approval for Export by Chinese Authority

Genetron Holdings Limited ("Genetron Health"), a China-based precision oncology company that covers full-cycle cancer care, announced that its independently developed detection kit for the novel coronavirus (Genetron SARS-CoV-2 RNA Test) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration. Additionally, the kit received approval for export from the relevant authorities in China.

Genetron Health was whitelisted as an approved COVID-19 reagent manufacturer by the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE), which means Genetron Health is granted to export Genetron SARS-CoV-2 RNA Test.

Prior to receiving the FDA EUA and being whitelisted by CCCMHPIE, Genetron SARS-CoV-2 RNA Test had already obtained CE marking (Registration Number: DE/CA20/IVD-Luxuslebenswelt-111/20); registration certification by European representative Luxus Lebenswelt GmbH; and its technical file also passed SGS review. All of these certifications indicate conformity with health, safety, and environmental protection standards for products sold within the European Economic Area.

Genetron SARS-CoV-2 RNA Test is an accurate, fast, contamination-free testing solution, which efficiently detects large-scale samples for the novel coronavirus. Features include:

Genetron Health has supplied its SARS-CoV-2 RNA Test to some high-risk areas in the world to aid in their large-scale coronavirus testing. Genetron Health is committed to fighting and controlling the COVID-19 pandemic with high-quality testing products and diligent assistance.

For any purchase requirements, please contact: BD-IC@genetronhealth.com

About Genetron Health

Genetron Health is a leading and fast-growing precision oncology company in China that aims to provide one-stop genomic profiling solutions for multiple scenarios covering early screening, diagnosis and monitoring, and biopharmaceutical services. The company collaborates with over 500 hospitals and dozens of biopharmaceutical companies and research institutions, and has developed a large proprietary genomic database.

Genetron Health has established R&D centers in both the United States and China, two manufacturing facilities with both ISO 13485:2016 certification and ISO 9001 2015 certification in China and five clinical laboratories in Beijing (CLIA accreditation and CAP certification), Shanghai, Hangzhou, Chongqing and Guangzhou. The R&D capacities of Genetron Health are supported by a best-in-class research and development team led by scientists at the forefront of cancer genomics research. The company has published many research papers in highly influential worldwide peer-reviewed scientific journals, such as Nature Genetics, Nature Communications, Cell Research and PNAS. For more information, please visit www.genetronhealth.com.

These press releases may also interest you

at 19:35
Technavio has been monitoring the railway fleet management market and it is poised to grow by USD 3.84 billion during 2020-2024, progressing at a CAGR of over 13% during the forecast period. The report offers an up-to-date analysis regarding the...

at 19:31
The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), and Biogen Inc. announced today that a new Phase III clinical study (AHEAD 3-45) of BAN2401, an anti-amyloid beta (A?) protofibril...

at 19:29
Back to Batoche is an annual celebration which brings people together from all across North America to recognize and celebrate the Métis Nation's rich culture, traditions and heritage. Since 1970, the festival has been held annually at the national...

at 19:25
On behalf of 20 West Coast universities and colleges, Gibson, Dunn & Crutcher LLP filed a lawsuit today challenging the July 6, 2020 order by the Trump Administration's Department of Homeland Security (DHS), U.S. Immigration and Customs Enforcement...

at 19:20
Technavio has been monitoring the sports fishing equipment market and it is poised to grow by USD 2.86 billion during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report offers an up-to-date analysis regarding the current...

at 19:18
The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic: FDA scientists have identified specific areas of the so-called spike proteins on the surface of the COVID-19-causing virus...

News published on 6 june 2020 at 06:45 and distributed by: